Shareprice
13 Jul 2024

Press & news

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

2024

23 February, 2024 FluoGuide A/S issues warrants to CFO News Corporate Action Other English Regulatory Listing Regulation IR
Copenhagen, Denmark, 23 February 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce...
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field...

2023

9 December, 2023 Chief Development Officer (CDO) Grethe Nørskov Rasmussen sells shares News Corporate Information Other Corporate Information English Regulatory Listing Regulation IR
Copenhagen, Denmark, 9 December 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today announces that...
8 December, 2023 FluoGuide raises SEK 12 million through exercise of warrants News Corporate Action Other English Regulatory MAR IR
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field...
29 November, 2023 FluoGuide A/S publishes interim report for the period January – September 2023 News English Regulatory Listing Regulation Report Interim Q3 IR
Copenhagen, Denmark, 29 November 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its...
13 November, 2023 FluoGuide announces FG001 meets primary endpoint in phase llb trial in aggressive brain cancer News Corporate Action Other English Regulatory MAR IR
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field...
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field...
3 October, 2023 FluoGuide receives FDA Orphan Drug Designation for FG001 in high-grade glioma News Corporate Action Other English Regulatory MAR IR
Copenhagen, Denmark – FluoGuide A/S (OMX: FLUO “FluoGuide” or the “Company”), a pioneer in the cutting-edge...
8 September, 2023 FluoGuide receives Danish award for the best share price performance since IPO News Corporate Action Other English IR
Copenhagen, Denmark, 8 September 2023 – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the...

Calendar &
upcoming reports


29 August 2024

Q2 report 2024


28 November 2024

Q3 report 2024


27 February 2025

Annual report 2024

Show all posts